Zurich Cantonal Bank’s Alpine Immune Sciences Inc ALPN Stock Holding History

Zurich Cantonal Bank’s Portfolio ALPN Stock Details ALPN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-8,006	Closed	-$317K	–	2739
2024 Q1	$317K	Sell	8,006 -1,532	-16%	-$45.2K	﹤0.01%	1785
2023 Q4	$182K	Buy	+9,538	New	+$133K	﹤0.01%	2138
2023 Q1	–	Sell	-1,714	Closed	-$12.6K	–	2883
2022 Q4	$12.6K	Sell	1,714 -331	-16%	-$2.12K	﹤0.01%	2793
2022 Q3	$15K	Hold	2,045	–	–	﹤0.01%	2839
2022 Q2	$17K	Sell	2,045 -212	-9%	-$1.83K	﹤0.01%	2813
2022 Q1	$20K	Buy	+2,257	New	+$19.5K	﹤0.01%	2666

Zurich Cantonal Bank's ALPN Position: Q2 2024 in Review

Zurich Cantonal Bank sold out of Alpine Immune Sciences Inc (ALPN) in Q2 2024, closing a stake of 8,006 shares — an estimated $317K sold.

Zurich Cantonal Bank first reported a position in ALPN in Q1 2022 and held it in 6 quarters. The position peaked at $317K in Q1 2024. 0 funds tracked by Wall St. Rank hold ALPN as of Q2 2024.

Zurich Cantonal Bank reported no remaining Alpine Immune Sciences Inc position as of Q2 2024 after selling out during the quarter.
Zurich Cantonal Bank sold 8,006 Alpine Immune Sciences Inc shares in Q2 2024, an estimated $317K.
Zurich Cantonal Bank first reported a position in Alpine Immune Sciences Inc in Q1 2022 and held it in 6 quarters.
Zurich Cantonal Bank's Alpine Immune Sciences Inc position peaked at $317K in Q1 2024.
0 funds tracked by Wall St. Rank held Alpine Immune Sciences Inc as of Q2 2024.

Based on Zurich Cantonal Bank's 13F filing for Q2 2024, filed 29 Jul 2024.